Nautilus Biotechnology, Inc. Quarterly Return On Assets in % from Q4 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Nautilus Biotechnology, Inc. quarterly/annual Return On Assets history and growth rate from Q4 2021 to Q3 2024.
  • Nautilus Biotechnology, Inc. Return On Assets for the quarter ending September 30, 2024 was -24.9 %, a 39.6% decline year-over-year.
  • Nautilus Biotechnology, Inc. annual Return On Assets for 2023 was -19.6 %, a 23.9% decline from 2022.
  • Nautilus Biotechnology, Inc. annual Return On Assets for 2022 was -15.8 %, a 4.29% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -24.9 -7.07 -39.6% Jul 1, 2024 Sep 30, 2024
Q2 2024 -23.5 -6.69 -39.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -21.7 -5.68 -35.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -19.6 -3.78 -23.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 -17.9 -1.69 -10.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -16.8 -0.8 -5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -16 -1.24 -8.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -15.8 -0.65 -4.29% Oct 1, 2022 Dec 31, 2022
Q3 2022 -16.2 Jul 1, 2022 Sep 30, 2022
Q2 2022 -16 Apr 1, 2022 Jun 30, 2022
Q1 2022 -14.8 Jan 1, 2022 Mar 31, 2022
Q4 2021 -15.2 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.